Jeena Sikho Lifecare's EBIT per Share for the
three
months ended in Mar. 2026 was ₹5.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹24.91.
During the past 12 months, the average EBIT per Share Growth Rate of Jeena Sikho Lifecare was 170.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 86.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 86.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Jeena Sikho Lifecare's EBIT per Share or its related term are showing as below:
NSE:JSLL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 16.2 Med: 82.7 Max: 96
Current: 86.2
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Jeena Sikho Lifecare was 96.00% per year. The lowest was 16.20% per year. And the median was 82.70% per year.
NSE:JSLL's 3-Year EBIT Growth Rate is ranked better than 96.42% of 531
companies
in the Healthcare Providers & Services industry
Industry Median: 11.7
vs NSE:JSLL: 86.20
Jeena Sikho Lifecare (NSE:JSLL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Jeena Sikho Lifecare EBIT per Share Related Terms
Jeena Sikho Lifecare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹24.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare (NSE:JSLL) has a EBIT per Share of ₹24.91 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Jeena Sikho Lifecare and its competitors. According to the industry distribution chart, Jeena Sikho Lifecare ranks #19 out of 531 companies in the Healthcare Providers & Services industry, placing it in the top 3.6%.
Is Jeena Sikho Lifecare's EBIT per Share too high?
Jeena Sikho Lifecare's current EBIT per Share is ₹24.91. Based on the distribution chart, Jeena Sikho Lifecare ranks #19 out of 531 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #19 out of 531 companies for EBIT per Share. This places Jeena Sikho Lifecare in the top 4% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.70, based on 531 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current EBIT per Share is ₹24.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current EBIT per Share is ₹24.91. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current EBIT per Share is ₹24.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
EBIT per Share: ₹24.91
GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
